Altimmune, Inc. (ALT)
Across 21 earnings reports since May 17, 2021, Altimmune, Inc. (ALT) has a clear post-earnings pattern. It moves ±7.52% on average after reporting and finishes higher 81.0% of the time. Its largest post-earnings gain was +29.12% (Nov 12, 2024) and its largest decline was -17.92% (Mar 05, 2026). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings reactions
How ALT moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±7.52%
Positive %
81.0%
Negative %
19.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 13, 2026 | ☀ PRE | -1.63% | open_in_new |
| Mar 05, 2026 | ☀ PRE | -17.92% | open_in_new |
| Nov 06, 2025 | ☀ PRE | +5.07% | open_in_new |
| Aug 12, 2025 | ☀ PRE | +7.1% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±7.52%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260616 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260513 | open_in_new SEC.gov |
| 8-K | 20260513 | open_in_new SEC.gov |
| S-8 | 20260513 | open_in_new SEC.gov |
| 4 | 20260501 | open_in_new SEC.gov |
| 4 | 20260501 | open_in_new SEC.gov |
| 4 | 20260501 | open_in_new SEC.gov |
| 4 | 20260501 | open_in_new SEC.gov |
| 4 | 20260501 | open_in_new SEC.gov |
Frequently asked about ALT earnings
When does Altimmune, Inc. report earnings next? expand_more
Altimmune, Inc. (ALT)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ALT stock move after earnings? expand_more
Over 21 reports, ALT has moved an average of ±7.52% the session after earnings, closing higher 81.0% of the time.
What was ALT's biggest post-earnings move? expand_more
ALT's largest post-earnings gain on record was +29.12% on Nov 12, 2024, and its largest decline was -17.92% on Mar 05, 2026.
Where can I find Altimmune, Inc.'s SEC filings? expand_more
All of Altimmune, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07